Similar articles

• Scare over oral contraceptives. Committee's action will undermine further research and development.

  Wynn V, Crook D, Godsland IF, Stevenson JC. Wynn V, et al. BMJ. 1995 Dec 16;311(7020):1639-40. doi: 10.1136/bmj.311.7020.1639c. BMJ. 1995. PMID: 8555822 Free PMC article. No abstract available.
• Third generation oral contraception and venous thromboembolism.

  McPherson K. McPherson K. BMJ. 1996 Jan 13;312(7023):68-9. doi: 10.1136/bmj.312.7023.68. BMJ. 1996. PMID: 8555921 Free PMC article. No abstract available.
• Scare over oral contraceptives. Effect on behaviour of women attending a family planning clinic.

  Armstrong JL, Reid M, Bigrigg A. Armstrong JL, et al. BMJ. 1995 Dec 16;311(7020):1637. doi: 10.1136/bmj.311.7020.1637. BMJ. 1995. PMID: 8555812 Free PMC article. No abstract available.
• The truth about oral contraceptives and venous thromboembolism.

  Shulman LP, Goldzieher JW. Shulman LP, et al. J Reprod Med. 2003 Nov;48(11 Suppl):930-8. J Reprod Med. 2003. PMID: 14686030 Review.
• A review of post-marketing safety and surveillance data for oral contraceptives containing norgestimate and ethinyl estradiol.

  Lippman JS, Shangold GA. Lippman JS, et al. Int J Fertil Womens Med. 1997 Jul-Aug;42(4):230-9. Int J Fertil Womens Med. 1997. PMID: 9309456 Review. No abstract available.